Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. proof of concept in rats

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Delbosc, Sandrine ^a,b   Alsac, Jean Marc ^a,d   Journe, Clement ^a,b   Louedec, Liliane ^a,b   Castier, Yves ^c   Bonnaure Mallet, Martine ^e   Ruimy, Raymond ^c   Rossignol, Patrick ^f   Bouchard, Philippe ^b,g   Michel, Jean Baptiste ^a,b   Meilhac, Olivier ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^f UNIVERSITÉ DE LORRAINE   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; CELL DNA; PRIMER DNA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RAT; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS; RATTUS;

AGED; AGED, 80 AND OVER; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; PORPHYROMONAS GINGIVALIS; RATS;

EID: 79955016349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018679     Document Type: Article

References (63)

1. Michel JB, (2001) Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol 21: 1389-1392.
2. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, et al. (2007) Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 27: 1259-1268.
3. Sakalihasan N, Limet R, Defawe OD, (2005) Abdominal aortic aneurysm. Lancet 365: 1577-1589.
4. Kurvers H, Veith FJ, Lipsitz EC, Ohki T, Gargiulo NJ, et al. (2004) Discontinuous, staccato growth of abdominal aortic aneurysms. J Am Coll Surg 199: 709-715.
5. Limet R, Sakalihassan N, Albert A, (1991) Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14: 540-548.
6. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, et al. (2002) Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161: 1701-1710.
7. Touat Z, Ollivier V, Dai J, Huisse MG, Bezeaud A, et al. (2006) Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168: 1022-1030.
8. Dejouvencel T, Feron D, Rossignol P, Sapoval M, Kauffmann C, et al. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 30: 269-275.
9. Houard X, Rouzet F, Touat Z, Philippe M, Dominguez M, et al. (2007) Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol 212: 20-28.
10. Houard X, Touat Z, Ollivier V, Louedec L, Philippe M, et al. (2009) Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 82: 532-541.
11. Houard X, Ollivier V, Louedec L, Michel JB, Back M, (2009) Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. Faseb J 23: 1376-1383.
12. Fontaine V, Touat Z, Mtairag el M, Vranckx R, Louedec L, et al. (2004) Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 164: 2077-2087.
13. Hannawa KK, Eliason JL, Woodrum DT, Pearce CG, Roelofs KJ, et al. (2005) L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 112: 241-247.
14. Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M, (2009) Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J 59: 197-209.
15. Bouchard P, Boutouyrie P, D'Aiuto F, Deanfield J, Deliargyris E, et al. (2010) European workshop in periodontal health and cardiovascular disease consensus document. European Heart Journal Supplements 12 (Supplement B pp. B13-B22.
16. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, et al. (2009) The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 80: 1021-1032.
17. Jimenez M, Krall EA, Garcia RI, Vokonas PS, Dietrich T, (2009) Periodontitis and incidence of cerebrovascular disease in men. Ann Neurol 66: 505-512.
18. Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ, (2009) Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 58: 1568-1575.
19. Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, et al. (2009) Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 24: 64-68.
20. Nakano K, Wada K, Nomura R, Nemoto H, Inaba H, et al. (2010) Characterization of aortic aneurysms in cardiovascular disease patients harboring Porphyromonas gingivalis. Oral Dis.
21. Aoyama N, Suzuki J, Wang D, Ogawa M, Kobayashi N, et al. (2010) Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res.
22. Fitzgerald JR, Loughman A, Keane F, Brennan M, Knobel M, et al. (2006) Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol 59: 212-230.
23. Bamford CV, Fenno JC, Jenkinson HF, Dymock D, (2007) The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation. Infect Immun 75: 4364-4372.
24. Imamura T, Travis J, Potempa J, (2003) The biphasic virulence activities of gingipains: activation and inactivation of host proteins. Curr Protein Pept Sci 4: 443-450.
25. Pathirana RD, O'Brien-Simpson NM, Veith PD, Riley PF, Reynolds EC, (2006) Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis. Microbiology 152: 2381-2394.
26. Olczak T, Simpson W, Liu X, Genco CA, (2005) Iron and heme utilization in Porphyromonas gingivalis. FEMS Microbiol Rev 29: 119-144.
27. Kauffmann C, Tang A, Dugas A, Therasse E, Oliva V, et al. (2009) Clinical validation of a software for quantitative follow-up of abdominal aortic aneurysm maximal diameter and growth by CT angiography. Eur J Radiol.
28. Dejouvencel T, Feron D, Rossignol P, Sapoval M, Kauffmann C, et al. (2010) Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 30: 269-275.
29. Allaire E, Mandet C, Bruneval P, Bensenane S, Becquemin JP, et al. (1996) Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat. Transplantation 62: 794-803.
30. Leclercq A, Houard X, Loyau S, Philippe M, Sebbag U, et al. (2007) Topology of protease activities reflects atherothrombotic plaque complexity. Atherosclerosis 191: 1-10.
31. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, et al. (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-625.
32. Li L, Messas E, Batista EL Jr, Levine RA, Amar S, (2002) Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105: 861-867.
33. Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, et al. (2008) Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects. J Periodontal Res 43: 103-110.
34. Mtairag el M, Houard X, Rais S, Pasquier C, Oudghiri M, et al. (2002) Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions. Arterioscler Thromb Vasc Biol 22: 1824-1831.
35. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
36. Wartha F, Beiter K, Normark S, Henriques-Normark B, (2007) Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 10: 52-56.
37. Wang Y, Li M, Stadler S, Correll S, Li P, et al. (2009) Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184: 205-213.
38. Margraf S, Logters T, Reipen J, Altrichter J, Scholz M, et al. (2008) Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock 30: 352-358.
39. Demmer RT, Desvarieux M, (2006) Periodontal infections and cardiovascular disease: the heart of the matter. J Am Dent Assoc 137 (Suppl): 14S-20S; quiz 38S.
40. Meurman JH, Sanz M, Janket SJ, (2004) Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15: 403-413.
41. Soolari AS, Champagne C, Punzi JS, Amar S, Van Dyke TE, (1999) Serum modulation of neutrophil response to Porphyromonas gingivalis LPS in periodontal disease. J Int Acad Periodontol 1: 101-109.
42. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16: 887-896.
43. Kim HS, Cho JH, Park HW, Yoon H, Kim MS, et al. (2002) Endotoxin-neutralizing antimicrobial proteins of the human placenta. J Immunol 168: 2356-2364.
44. Parseghian MH, Luhrs KA, (2006) Beyond the walls of the nucleus: the role of histones in cellular signaling and innate immunity. Biochem Cell Biol 84: 589-604.
45. Ma AC, Kubes P, (2008) Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 6: 415-420.
46. Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, et al. (2004) Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 28: 553-558.
47. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L, (2000) The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20: 281-285.
48. Martinez-Pinna R, Lindholt JS, Blanco-Colio LM, Dejouvencel T, Madrigal-Matute J, et al. (2010) Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. Atherosclerosis 212: 333-338.
49. Nyberg A, Skagius E, Englund E, Nilsson I, Ljungh A, et al. (2008) Abdominal aortic aneurysm and the impact of infectious burden. Eur J Vasc Endovasc Surg 36: 292-296.
50. Blanchard JF, Armenian HK, Peeling R, Friesen PP, Shen C, et al. (2000) The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm: case-control study. Clin Infect Dis 30: 946-947.
51. Lindholt JS, Ostergard L, Henneberg EW, Fasting H, Andersen P, (1998) Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg 15: 161-164.
52. Falkensammer B, Duftner C, Seiler R, Pavlic M, Walder G, et al. (2007) Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology. Eur J Clin Microbiol Infect Dis 26: 141-145.
53. Sodeck G, Domanovits H, Khanakah G, Schillinger M, Thalmann M, et al. (2004) The role of Chlamydia pneumoniae in human aortic disease-a hypothesis revisited. Eur J Vasc Endovasc Surg 28: 547-552.
54. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, et al. (2001) Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34: 606-610.
55. Golub LM, Sorsa T, Lee HM, Ciancio S, Sorbi D, et al. (1995) Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22: 100-109.
56. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R, (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119: 2209-2216.
57. Haffajee AD, Socransky SS, Gunsolley JC, (2003) Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 8: 115-181.
58. Grenier D, Roy E, Mayrand D, (2003) Modulation of Porphyromonas gingivalis proteinase activity by suboptimal doses of antimicrobial agents. J Periodontol 74: 1316-1319.
59. Imamura T, Matsushita K, Travis J, Potempa J, (2001) Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 45: 2871-2876.
60. Forner L, Larsen T, Kilian M, Holmstrup P, (2006) Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 33: 401-407.
61. Perez-Chaparro PJ, Lafaurie GI, Gracieux P, Meuric V, Tamanai-Shacoori Z, et al. (2009) Distribution of Porphyromonas gingivalis fimA genotypes in isolates from subgingival plaque and blood sample during bacteremia. Biomedica 29: 298-306.
62. Burnette-Curley D, Wells V, Viscount H, Munro CL, Fenno JC, et al. (1995) FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun 63: 4669-4674.
63. Viscount HB, Munro CL, Burnette-Curley D, Peterson DL, Macrina FL, (1997) Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun 65: 994-1002.